Dancer
0 likes255 views
1) HARVONI is a new treatment for chronic hepatitis C genotype 1 that combines two drugs (ledipasvir and sofosbuvir) into a single daily pill for 12 weeks. In clinical studies, 96-99% of patients without prior treatment were cured. 2) For certain patients without cirrhosis, HARVONI was shown to be highly effective when taken for only 8 weeks. 3) HARVONI offers improvements over previous hepatitis C treatments as it contains no interferon, no ribavirin, requires only one pill taken once daily, and has cure rates as high as 99% for those without prior treatment.
1 of 1
Download to read offline
Recommended
Phillips Pt Case Pres Chronic Diarrhea
Phillips Pt Case Pres Chronic Diarrheaflutterbye_xo
油
This document discusses a case of an 82-year-old female patient with chronic diarrhea who was seeking paregoric, an older medication containing morphine that was no longer manufactured. The patient had previously used paregoric successfully to treat her diarrhea. The pharmacist compounded a paregoric formulation for the patient which provided relief of her symptoms. The document provides background on irritable bowel syndrome and paregoric, and discusses alternatives for treating diarrhea before concluding the patient was satisfied with the compounded paregoric.Hiv and pregnancy
Hiv and pregnancyacatanzaro
油
This document summarizes recommendations for prenatal care and delivery of a 28-year-old HIV-positive pregnant woman. The plan includes monitoring the woman's CD4 count and viral load during pregnancy, referring her to an HIV specialist, providing antiretroviral therapy to reduce transmission risk, counseling on transmission risks and prevention, and treating the newborn after delivery to further reduce transmission risk. Mode of delivery will depend on the woman's viral load at delivery, with C-section recommended if her viral load is over 1,000 copies/mL to lower transmission risk.Management of hepatitis c in pregnancy
Management of hepatitis c in pregnancyBasem Hamed
油
This document provides guidance on the management of Hepatitis C in pregnancy. It recommends screening all pregnant women for HCV at their first prenatal visit and retesting those at high risk. For HCV-positive patients, it advises monitoring liver enzymes during pregnancy, discussing transmission risks and treatment with the patient, and considering referral to a hepatology clinic. It also provides guidance on intrapartum care, postpartum management including breastfeeding, neonatal follow-up testing, and contraception during and after antiviral therapy.Newborn screening kuwait
Newborn screening kuwaitNewborn Screening KW
油
Newborn screening involves testing newborns for treatable genetic and metabolic disorders. It is a public health program that aims to identify affected infants early to prevent health problems. The document discusses the goals and components of newborn screening programs, including the diseases tested for, sample collection procedures, screening techniques, result interpretation, and confirmatory testing. It provides statistics on the increasing number of babies screened in Kuwait each year, from around 3,000 in 2005 to over 31,000 in 2014, demonstrating greater coverage of newborns over time.kuwait national newborn screening program
kuwait national newborn screening programNewborn Screening KW
油
Kuwait has established a national newborn screening program that screens all newborns for 22 disorders using tandem mass spectrometry and other methods. The program started in 2005 screening high-risk newborns for 2 disorders and expanded over time, becoming a universal screening program in 2014 that screens over 60,000 newborns annually across both governmental and private hospitals. The screening helps detect treatable genetic disorders early to improve newborn health outcomes and reduce disability and disease burden. Challenges in implementing the program were addressed through strategic planning, leadership, education, and integrating screening into the public health system to ensure sustainability.Say NO to drugs .. Dr.Padmesh
Say NO to drugs .. Dr.PadmeshDr Padmesh Vadakepat
油
Dr. Padmesh, a pediatrician, gave a presentation on International Day Against Drug Abuse. He discussed that drugs are chemical substances that affect the body's normal functioning. People often take drugs due to peer pressure, trying to escape problems, curiosity, or just wanting to feel good. However, drug use can have serious side effects and influence a person's health, education, relationships, career, and happiness. The presentation emphasized saying no to drugs and avoiding addiction.pediatrics.Rap.(dr.adnan)
pediatrics.Rap.(dr.adnan)student
油
RAP, or recurrent abdominal pain, affects about 10% of school-aged children and is characterized by recurring midline abdominal pain that interrupts normal activities on a monthly basis for at least 3 months. While an organic cause can be found in about 10% of cases, the majority are considered functional pain. The evaluation process aims to rule out potential organic causes through history, physical exam, and selective testing before establishing a diagnosis of functional pain. Reassurance and a return to normal activities are key to treatment, while medications are generally not helpful for functional recurrent abdominal pain.Epilepsy
EpilepsyAinah Mahani Mahaiyuddin
油
This document provides guidance for prenatal care of women with epilepsy. It recommends taking folic acid prior to and during pregnancy to reduce risks. Women should be informed about risks of epilepsy, anti-seizure medications, and potential birth defects. Medications generally do not need changing if epilepsy is well-controlled, but converting to a single drug may be considered. Lower and monitored doses aim to prevent seizures while minimizing harm. Ultrasounds are suggested to monitor the fetus. Vitamin K supplementation is advised for women on certain anti-seizure medications. The newborn should also receive Vitamin K, and breastfeeding is encouraged. Risk of seizures increases around delivery, so safety precautions are important postpartum.001 holistic approach sick under 5 y.o.
001 holistic approach sick under 5 y.o.syaija
油
This document describes the holistic/integrated approach to managing illness in children under 5 years old through the Integrated Management of Childhood Illness (IMCI) program. It discusses the rationale for an integrated strategy given that the major causes of childhood death are often associated with multiple conditions. The IMCI strategy involves improving health workers' case management skills, strengthening the health system, and improving family/community practices. The clinical guidelines focus on classifying illnesses rather than diagnoses and address the major symptoms through limited signs and essential treatments. The case management process involves assessing complaints, checking for danger signs, classifying illnesses, identifying treatments, providing counseling and follow-up care.Pharmacists - your partner in using medicine responsibly
Pharmacists - your partner in using medicine responsiblyZinatFatema
油
Pharmacists ensure that prescribed medicine is clinically appropriate for the patient and provide information to ensure safe and effective use. The dispensing cycle involves receiving and validating prescriptions, gathering patient information, reviewing the prescribed medication for safety and compatibility, making a clinical decision, preparing and dispensing the medication with a final check, and issuing the medication to patients with clear instructions. Pharmacists partner with patients and doctors to use medicine responsibly.Newborn Screening | Infant Care | Health Care | Baby's First Test
Newborn Screening | Infant Care | Health Care | Baby's First Testjohndemello7
油
Baby's First Test is the nation's newborn screening education center for parents, health professionals, and the public on the newborn screening system.
Visit http://www.babysfirsttest.org/Kuwait newborn screening 3
Kuwait newborn screening 3Newborn Screening KW
油
Newborn screening involves testing newborns for treatable genetic and metabolic disorders. It is a public health program that aims to identify affected infants early to prevent health problems. The document discusses the goals and components of newborn screening programs, including the diseases tested for, sample collection procedures, screening techniques, result interpretation, and confirmatory testing. It provides statistics on the increasing number of babies screened in Kuwait over recent years, from around 3,000 in 2005 to over 31,000 in 2014.Nbs
NbsNewborn Screening KW
油
Newborn screening identifies treatable diseases in newborns through early blood tests. It aims to prevent brain damage, illness, or death through early detection and treatment before symptoms appear. The document discusses criteria for diseases and tests included in screening programs. It provides details on the 22 disorders detected in its screening panel using two analytical methods. Clinical presentations of some disorders are also described. Proper sample collection and handling are emphasized to ensure test validity.Biomedical Prevention: Testing - The NZ Strategic Context
Biomedical Prevention: Testing - The NZ Strategic ContextAustralian Federation of AIDS Organisations
油
This presentation on New Zealand's approach to HIV prevention was given by Shaun Robinson, Executive Director NZ AIDS Foundation, at the AFAO Members Forum - May 2015.New born screening
New born screeningraghavendra doddamani
油
The document discusses newborn screening in India, arguing that it is needed to prevent health issues. It outlines the components of newborn screening programs and principles from Wilson and Jungner. Internationally, most Western countries screen for various treatable genetic disorders. In India, pilot studies found higher rates of congenital hypothyroidism than the West. The document recommends starting screening for congenital hypothyroidism, congenital adrenal hyperplasia, and G6PD deficiency in urban Indian hospitals. It stresses the need for diagnostic confirmation, treatment facilities, and quality assurance before a national newborn screening program is implemented.UC Nursing CESDEV Imci
UC Nursing CESDEV Imciucnursingcesdev
油
The document provides guidelines for community health workers on assessing and classifying sick children aged 2 months to 5 years. It describes how to check for general danger signs, classify presenting symptoms like cough, difficulty breathing, diarrhea, fever, ear problems, and malnutrition. It also provides treatment guidelines based on the classification. The assessment involves asking questions, looking, listening and feeling. It aims to identify conditions like pneumonia, dehydration, malaria, measles and refer cases urgently if severe.Hepatitis A, B, and C its management and treatment
Hepatitis A, B, and C its management and treatmentJack Frost
油
The document provides information about Hepatitis A, B, and C including their prevention, medical treatment, nursing management, and patient self-care recommendations. It discusses vaccination as an important prevention strategy for Hepatitis A and B. Medical treatment for Hepatitis C typically involves antiviral medications like interferon and ribavirin. Nursing management focuses on education and psychosocial support. Self-care involves rest, hydration, avoiding activities or substances that could further impact the liver.
Hepatitis C Current progress in management
Hepatitis C Current progress in managementMainuddin Ahmed
油
A power point presentation on Hepatitis C virus on epidemiology, presentation, diagnosis and current treatment strategies we are practicing in BSMMU at a international standerd. 
Hepatitis C Treatment Questions
Hepatitis C Treatment QuestionsJenny Chan
油
This document discusses hepatitis C virus (HCV) and current treatment options. It provides the following key points:
- HCV is the most common blood-borne pathogen in the US, with around 3.2 million people chronically infected. Chronic infections often progress to cirrhosis over 20-30 years.
- New all-oral treatment regimens that do not require interferon are highly effective. Sofosbuvir-based combinations can achieve over 90% sustained virologic response rates.
- Treatment is now recommended for most patients with chronic HCV to prevent long-term complications like cirrhosis and liver cancer. However, costs remain very high, with prices over $80,000 for aHBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatiti...
HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatiti...PVI, PeerView Institute for Medical Education
油
Chair, Paul Kwo, MD, AGAF, FACG, FAASLD, prepared useful Practice Aids pertaining to hepatitis B for this CME/MOC activity titled HBV Is Primary! Your Role in the Call to Action to Eliminate Viral Hepatitis By 2030. For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3EYVafQ. CME/MOC credit will be available until March 21, 2024.HIV Pharmacotherapy in Pregnancy
HIV Pharmacotherapy in Pregnancydbridley
油
1) The document discusses pharmacological principles for treating HIV in pregnant women to reduce mother-to-child transmission.
2) Updated perinatal guidelines from 2007 recommend initiating HAART after 14 weeks of gestation and continuing treatment throughout pregnancy, labor, and delivery.
3) Clinical scenarios provide examples of applying the guidelines, such as recommending HAART, scheduled C-sections if viral load is high, and 6 weeks of infant ZDV treatment starting within hours of birth. pregnancy
pregnancyKrishna Gali
油
This document summarizes information about pregnancy, childbirth, and breastfeeding for women with hepatitis C (HCV). It notes that the risk of transmitting HCV from mother to infant is 4-7% and may be higher if the mother has a high viral load or HIV. It advises against HCV treatment during pregnancy due to potential birth defects from ribavirin. It provides no recommendations against pregnancy or procedures for HCV-positive women not on treatment. It recommends pediatric testing for children born to HCV-positive mothers and discusses considerations around family planning and HCV treatment timing. HIV mother-to-child-transmission
HIV mother-to-child-transmissionDiNa Maklad
油
Approximately 8,500 women living with HIV give birth annually in the US. Since the beginning of the AIDS epidemic, almost 5,000 children under age 13 who got HIV through perinatal transmission have died. New HIV infections in children have dramatically declined from 400,000 in 2009 to around 220,000 in 2014 due to efforts like the UNICEF Global Plan. Prevention of perinatal transmission is crucial since there is no HIV vaccine; it requires pregnant women to take antiretroviral therapy consistently during and after pregnancy and avoid breastfeeding. Challenges to prevention include not all pregnant women knowing their HIV status and inconsistent access to treatment.HIV TREATMENT PPT.pptx
HIV TREATMENT PPT.pptxmehulc001
油
HAART, or highly active antiretroviral therapy, involves using a combination of antiretroviral drugs to treat HIV. The goals of ART include increased survival, improved quality of life, reduction of viral load, immune reconstitution, and limiting drug toxicity while maintaining treatment options and adherence. Commonly used drug classes include NRTIs, NNRTIs, integrase inhibitors, and protease inhibitors. Treatment involves monitoring viral load, CD4 count, adverse effects, and potential treatment failure or immune reconstitution inflammatory syndrome. Guidelines provide recommendations on treatment initiation and first, second, and third-line regimens for both adults and children.Hepatitis-C-treatment-guidelines.pptx
Hepatitis-C-treatment-guidelines.pptxMariaFatima374066
油
Hepatitis C affects over 184 million people worldwide and is a major cause of chronic liver disease. It is caused by the hepatitis C virus and transmitted via contact with infected blood. New highly effective direct acting antiviral regimens can cure over 95% of infections and guidelines recommend treatment for all patients except those who will receive a liver transplant within 6 months. Treatment involves combinations of antiviral drugs tailored to hepatitis C genotype and cirrhosis status, with sustained virologic response assessed 12-24 weeks post treatment indicating cure.Covid 19 and pregnancy
Covid 19 and pregnancyjainshailesh2001
油
These are guidelines for patients and healthcare workers for corona virus in pregnancy.....Measures for prevention...these are guidelines by FOGSI and ACOGHpv vaccination 
Hpv vaccination ReetaSingh19
油
HPV vaccination provides protection against HPV strains that cause cervical cancer and genital warts. The FDA has approved several HPV vaccines, including a quadrivalent vaccine protecting against strains 16, 18, 6, and 11, and a bivalent vaccine protecting against 16 and 18. Vaccination is recommended between ages 9-14 with a two dose schedule, or ages 15 and older with a three dose schedule. HPV vaccination has been shown to be safe and effective with common side effects being mild local reactions. Screening is still recommended for vaccinated individuals as the vaccines do not protect against all cancer-causing HPV strains.Naco guidelines update 2015
Naco guidelines update 2015Nishant Prabhakar
油
early infant diagnosis and immunization and cotrimoxazole prophylaxis as well as breast feeding revised protocols More Related Content
What's hot (8)
001 holistic approach sick under 5 y.o.
001 holistic approach sick under 5 y.o.syaija
油
This document describes the holistic/integrated approach to managing illness in children under 5 years old through the Integrated Management of Childhood Illness (IMCI) program. It discusses the rationale for an integrated strategy given that the major causes of childhood death are often associated with multiple conditions. The IMCI strategy involves improving health workers' case management skills, strengthening the health system, and improving family/community practices. The clinical guidelines focus on classifying illnesses rather than diagnoses and address the major symptoms through limited signs and essential treatments. The case management process involves assessing complaints, checking for danger signs, classifying illnesses, identifying treatments, providing counseling and follow-up care.Pharmacists - your partner in using medicine responsibly
Pharmacists - your partner in using medicine responsiblyZinatFatema
油
Pharmacists ensure that prescribed medicine is clinically appropriate for the patient and provide information to ensure safe and effective use. The dispensing cycle involves receiving and validating prescriptions, gathering patient information, reviewing the prescribed medication for safety and compatibility, making a clinical decision, preparing and dispensing the medication with a final check, and issuing the medication to patients with clear instructions. Pharmacists partner with patients and doctors to use medicine responsibly.Newborn Screening | Infant Care | Health Care | Baby's First Test
Newborn Screening | Infant Care | Health Care | Baby's First Testjohndemello7
油
Baby's First Test is the nation's newborn screening education center for parents, health professionals, and the public on the newborn screening system.
Visit http://www.babysfirsttest.org/Kuwait newborn screening 3
Kuwait newborn screening 3Newborn Screening KW
油
Newborn screening involves testing newborns for treatable genetic and metabolic disorders. It is a public health program that aims to identify affected infants early to prevent health problems. The document discusses the goals and components of newborn screening programs, including the diseases tested for, sample collection procedures, screening techniques, result interpretation, and confirmatory testing. It provides statistics on the increasing number of babies screened in Kuwait over recent years, from around 3,000 in 2005 to over 31,000 in 2014.Nbs
NbsNewborn Screening KW
油
Newborn screening identifies treatable diseases in newborns through early blood tests. It aims to prevent brain damage, illness, or death through early detection and treatment before symptoms appear. The document discusses criteria for diseases and tests included in screening programs. It provides details on the 22 disorders detected in its screening panel using two analytical methods. Clinical presentations of some disorders are also described. Proper sample collection and handling are emphasized to ensure test validity.Biomedical Prevention: Testing - The NZ Strategic Context
Biomedical Prevention: Testing - The NZ Strategic ContextAustralian Federation of AIDS Organisations
油
This presentation on New Zealand's approach to HIV prevention was given by Shaun Robinson, Executive Director NZ AIDS Foundation, at the AFAO Members Forum - May 2015.New born screening
New born screeningraghavendra doddamani
油
The document discusses newborn screening in India, arguing that it is needed to prevent health issues. It outlines the components of newborn screening programs and principles from Wilson and Jungner. Internationally, most Western countries screen for various treatable genetic disorders. In India, pilot studies found higher rates of congenital hypothyroidism than the West. The document recommends starting screening for congenital hypothyroidism, congenital adrenal hyperplasia, and G6PD deficiency in urban Indian hospitals. It stresses the need for diagnostic confirmation, treatment facilities, and quality assurance before a national newborn screening program is implemented.UC Nursing CESDEV Imci
UC Nursing CESDEV Imciucnursingcesdev
油
The document provides guidelines for community health workers on assessing and classifying sick children aged 2 months to 5 years. It describes how to check for general danger signs, classify presenting symptoms like cough, difficulty breathing, diarrhea, fever, ear problems, and malnutrition. It also provides treatment guidelines based on the classification. The assessment involves asking questions, looking, listening and feeling. It aims to identify conditions like pneumonia, dehydration, malaria, measles and refer cases urgently if severe.Biomedical Prevention: Testing - The NZ Strategic Context
Biomedical Prevention: Testing - The NZ Strategic ContextAustralian Federation of AIDS Organisations
油
Similar to Dancer (20)
Hepatitis A, B, and C its management and treatment
Hepatitis A, B, and C its management and treatmentJack Frost
油
The document provides information about Hepatitis A, B, and C including their prevention, medical treatment, nursing management, and patient self-care recommendations. It discusses vaccination as an important prevention strategy for Hepatitis A and B. Medical treatment for Hepatitis C typically involves antiviral medications like interferon and ribavirin. Nursing management focuses on education and psychosocial support. Self-care involves rest, hydration, avoiding activities or substances that could further impact the liver.Hepatitis C Current progress in management
Hepatitis C Current progress in managementMainuddin Ahmed
油
A power point presentation on Hepatitis C virus on epidemiology, presentation, diagnosis and current treatment strategies we are practicing in BSMMU at a international standerd. Hepatitis C Treatment Questions
Hepatitis C Treatment QuestionsJenny Chan
油
This document discusses hepatitis C virus (HCV) and current treatment options. It provides the following key points:
- HCV is the most common blood-borne pathogen in the US, with around 3.2 million people chronically infected. Chronic infections often progress to cirrhosis over 20-30 years.
- New all-oral treatment regimens that do not require interferon are highly effective. Sofosbuvir-based combinations can achieve over 90% sustained virologic response rates.
- Treatment is now recommended for most patients with chronic HCV to prevent long-term complications like cirrhosis and liver cancer. However, costs remain very high, with prices over $80,000 for aHBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatiti...
HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatiti...PVI, PeerView Institute for Medical Education
油
Chair, Paul Kwo, MD, AGAF, FACG, FAASLD, prepared useful Practice Aids pertaining to hepatitis B for this CME/MOC activity titled HBV Is Primary! Your Role in the Call to Action to Eliminate Viral Hepatitis By 2030. For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3EYVafQ. CME/MOC credit will be available until March 21, 2024.HIV Pharmacotherapy in Pregnancy
HIV Pharmacotherapy in Pregnancydbridley
油
1) The document discusses pharmacological principles for treating HIV in pregnant women to reduce mother-to-child transmission.
2) Updated perinatal guidelines from 2007 recommend initiating HAART after 14 weeks of gestation and continuing treatment throughout pregnancy, labor, and delivery.
3) Clinical scenarios provide examples of applying the guidelines, such as recommending HAART, scheduled C-sections if viral load is high, and 6 weeks of infant ZDV treatment starting within hours of birth. pregnancy
pregnancyKrishna Gali
油
This document summarizes information about pregnancy, childbirth, and breastfeeding for women with hepatitis C (HCV). It notes that the risk of transmitting HCV from mother to infant is 4-7% and may be higher if the mother has a high viral load or HIV. It advises against HCV treatment during pregnancy due to potential birth defects from ribavirin. It provides no recommendations against pregnancy or procedures for HCV-positive women not on treatment. It recommends pediatric testing for children born to HCV-positive mothers and discusses considerations around family planning and HCV treatment timing. HIV mother-to-child-transmission
HIV mother-to-child-transmissionDiNa Maklad
油
Approximately 8,500 women living with HIV give birth annually in the US. Since the beginning of the AIDS epidemic, almost 5,000 children under age 13 who got HIV through perinatal transmission have died. New HIV infections in children have dramatically declined from 400,000 in 2009 to around 220,000 in 2014 due to efforts like the UNICEF Global Plan. Prevention of perinatal transmission is crucial since there is no HIV vaccine; it requires pregnant women to take antiretroviral therapy consistently during and after pregnancy and avoid breastfeeding. Challenges to prevention include not all pregnant women knowing their HIV status and inconsistent access to treatment.HIV TREATMENT PPT.pptx
HIV TREATMENT PPT.pptxmehulc001
油
HAART, or highly active antiretroviral therapy, involves using a combination of antiretroviral drugs to treat HIV. The goals of ART include increased survival, improved quality of life, reduction of viral load, immune reconstitution, and limiting drug toxicity while maintaining treatment options and adherence. Commonly used drug classes include NRTIs, NNRTIs, integrase inhibitors, and protease inhibitors. Treatment involves monitoring viral load, CD4 count, adverse effects, and potential treatment failure or immune reconstitution inflammatory syndrome. Guidelines provide recommendations on treatment initiation and first, second, and third-line regimens for both adults and children.Hepatitis-C-treatment-guidelines.pptx
Hepatitis-C-treatment-guidelines.pptxMariaFatima374066
油
Hepatitis C affects over 184 million people worldwide and is a major cause of chronic liver disease. It is caused by the hepatitis C virus and transmitted via contact with infected blood. New highly effective direct acting antiviral regimens can cure over 95% of infections and guidelines recommend treatment for all patients except those who will receive a liver transplant within 6 months. Treatment involves combinations of antiviral drugs tailored to hepatitis C genotype and cirrhosis status, with sustained virologic response assessed 12-24 weeks post treatment indicating cure.Covid 19 and pregnancy
Covid 19 and pregnancyjainshailesh2001
油
These are guidelines for patients and healthcare workers for corona virus in pregnancy.....Measures for prevention...these are guidelines by FOGSI and ACOGHpv vaccination
Hpv vaccination ReetaSingh19
油
HPV vaccination provides protection against HPV strains that cause cervical cancer and genital warts. The FDA has approved several HPV vaccines, including a quadrivalent vaccine protecting against strains 16, 18, 6, and 11, and a bivalent vaccine protecting against 16 and 18. Vaccination is recommended between ages 9-14 with a two dose schedule, or ages 15 and older with a three dose schedule. HPV vaccination has been shown to be safe and effective with common side effects being mild local reactions. Screening is still recommended for vaccinated individuals as the vaccines do not protect against all cancer-causing HPV strains.Naco guidelines update 2015
Naco guidelines update 2015Nishant Prabhakar
油
early infant diagnosis and immunization and cotrimoxazole prophylaxis as well as breast feeding revised protocols Ranitidine : Indications, Uses, Dosage
Ranitidine : Indications, Uses, DosageMedical Dialogues
油
Ranitidine is a gastro-intestinal agent that inhibits histamine H2 receptors.
The histamine H2 receptor antagonist ranitidine is used to treat erosive esophagitis, Zollinger-Ellison syndrome, gastric ulcers, GERD, and duodenal ulcers.Perinatal Hepatitis B Webinar Final Updated 12112017 (1).pptx
Perinatal Hepatitis B Webinar Final Updated 12112017 (1).pptxShireenzada1
油
This presentation provides guidance for caring for infants born to hepatitis B infected mothers. It discusses the implications of perinatal hepatitis B infection, describing how the virus is transmitted from mother to infant and the importance of immunoprophylaxis to prevent transmission. It outlines the recommended immunization schedule for infants exposed to hepatitis B, which includes administering hepatitis B immune globulin and vaccine within 12 hours of birth, followed by completion of the hepatitis B vaccine series by 6 months of age. It also describes the importance of post-vaccination serologic testing between 9-12 months to determine if the infant developed immunity or requires additional vaccination.A Modern Take on Hepatitis Immunization: Overcoming Today's Hurdles With Rece...
A Modern Take on Hepatitis Immunization: Overcoming Today's Hurdles With Rece...PVI, PeerView Institute for Medical Education
油
Co-Chairs, Robert G Gish, MD, and Stacey B. Trooskin, MD, PhD, prepared useful Practice Aids pertaining to hepatitis for this CME/NCPD/CPE/AAPA/IPCE activity titled A Modern Take on Hepatitis Immunization: Overcoming Today's Hurdles With Recent Guidelines and Practical Strategies. For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4bEIRUJ. CME/NCPD/CPE/AAPA/IPCE credit will be available until August 14, 2025.HIV DIAGNOSIS & MANAGEMENT IN CHILDREN
HIV DIAGNOSIS & MANAGEMENT IN CHILDRENShiva Polisetty
油
This document discusses the diagnosis and management of HIV in children. It covers:
- Diagnosis of HIV in infants less than 18 months old using virological tests like PCR and more than 18 months using antibody tests.
- Recommended testing schedules for infants based on their risk of exposure.
- Clinical criteria for diagnosis where testing is unavailable.
- Management includes prophylaxis, antiretroviral therapy, treating opportunistic infections, adequate nutrition and immunization.
- Details various antiretroviral drug classes and regimens recommended.
- Side effects of different drug classes like NRTIs, NNRTIs and PIs.
- Nutrition, immunization guidelines and postHiv infection in pregnancy
Hiv infection in pregnancyMpPm4
油
This document provides guidelines for managing HIV infection in pregnancy. It discusses counseling pregnant women who test positive for HIV, antenatal care including investigations and treatment with antiretroviral therapy, preventing mother-to-child transmission through medication and delivery methods, care during labor and delivery, testing and treatment for infants, and postpartum care of both mother and baby. The goal is to reduce the risk of transmitting HIV from mother to child to less than 2% through screening, testing, antiretroviral treatment, and modifying delivery and infant feeding practices.Hep day 7 for slide share
Hep day 7 for slide sharemunir salman
油
This document discusses viral hepatitis, focusing on types A, B, C, and E. It provides details on the clinical features, transmission, prevention and laboratory diagnosis of each type. For hepatitis B (HBV), it describes a case of a 28-year-old woman admitted with jaundice who was at risk of HBV transmission through tattooing and acupuncture sessions. HBV transmission occurs primarily through blood and body fluids. Screening is recommended for high-risk groups such as healthcare workers, immigrants from endemic areas, and household contacts of HBV patients.HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatiti...
HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatiti...PVI, PeerView Institute for Medical Education
油
A Modern Take on Hepatitis Immunization: Overcoming Today's Hurdles With Rece...
A Modern Take on Hepatitis Immunization: Overcoming Today's Hurdles With Rece...PVI, PeerView Institute for Medical Education
油
Dancer
- 1. to be ready I Am HEPATITIS UREDCIn clinical studies, 9699% of patients who had no prior treatment were cured with just 12 weeks of therapy.* The ONE Youve been waiting for * In a study of 865 patients with genotype 1 Hep C and no prior Hep C treatment, with or without advanced liver disease (cirrhosis), 99% (210 out of 213) of those who received HARVONI once daily for 12 weeks were cured. In a separate study of 647 patients with genotype 1 Hep C, with no prior Hep C treatment and without cirrhosis, 96% (208 out of 216) of those who received HARVONI once daily for 12 weeks were cured. In the study of 647 patients with genotype 1 Hep C, with no prior Hep C treatment and without cirrhosis, 97% (119 out of 123) of those with lower levels of the virus (less than 6 million IU/mL) who received HARVONI once daily for 8 weeks were cured. Today Theres HARVONI. A breakthrough treatment for chronic hepatitis C genotype 1 in adults. HARVONI is a prescription medicine for chronic (lasting a long time) hepatitis C (Hep C) that combines two drugs (ledipasvir and sofosbuvir) in one pill. It is not known if HARVONI is safe and effective in children under 18 years of age. HARVONI has been proven to cure up to 99% of patients whove had no prior Hep C treatment.* HARVONI is the one and only cure thats one pill, once a day for 12 weeks. And for certain patients, HARVONI has been shown to be highly effective in as little as 8 weeks of treatment. Your Hep C specialist will decide what treatment length is right for you. Cure means the Hep C virus is not detected in the blood when measured three or more months after treatment is completed. With HARVONI, theres no interferon, no ribavirin, and no complicated regimens. So, if you dont want to live with the uncertainties of Hep C, now may be the time to talk to your Hep C specialist about HARVONI. Important Safety Information What should I tell my healthcare provider before taking HARVONI? If you have: liver problems other than hepatitis C infection; severe kidney problems or are on dialysis; any other medical condition; or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if HARVONI will harm your unborn baby or pass into your breast milk. If you take amiodarone (Cordarone速, Nexterone速, Pacerone速), rifampin (Rifadin速, Rifamate速, Rifater速),St.JohnswortoraproductthatcontainsSt.Johnswort.Tellyourhealthcareprovider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. HARVONI may affect the way other medicines work, and other medicines may affect how HARVONI works. You should not take HARVONI if you also take other medicines that contain sofosbuvir (SOVALDI速). What are the most common side effects of HARVONI? Common side effects include tiredness and headache. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Are you ready for HARVONI? Ask your Hep C specialist if HARVONI is right for you and visit HARVONI.com or call 1-844-READY41. Please see Brief Summary of full Prescribing Information on the following page.